Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. Mylan applies one global quality standard across our facilities, and across our product line regardless of market. At Mylan, whether it’s a medication for millions or for a handful of people our priorities are to meet or exceed industry standards.

Canonsburg, US
Size (employees)
35,000 (est)
Mylan was founded in 1961 and is headquartered in Canonsburg, US
Report incorrect company information

Key People/Management at Mylan

Heather Bresch

Heather Bresch

Chief Executive Officer

Mylan Office Locations

Mylan has an office in Canonsburg
Canonsburg, US (HQ)
1000 Mylan Boulevard
Show all (1)
Report incorrect company information

Mylan Financials and Metrics

Mylan Financials

Mylan's revenue was reported to be $7.65 b in FY, 2014 which is a 11.5% increase from the previous period.

Revenue (FY, 2014)

7.6 b

Revenue growth (FY, 2013 - FY, 2014), %


Gross profit (FY, 2014)

3.5 b

Gross profit margin (FY, 2014), %


Net income (FY, 2014)

933.1 m

Market capitalization (5-Feb-2018)

22.6 b

Cash (4-Feb-2018)

28.7 k
Mylan's current market capitalization is $22.6 b.
USDFY, 2013FY, 2014


6.9 b7.6 b

Revenue growth, %


Cost of goods sold

3.9 b4.2 b

Gross profit

3 b3.5 b
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


2.5 k5.9 k1.8 k163 32 5.1 k5.2 k28.9 k15.3 k28.7 k

Accounts Receivable

975 372 2.5 k17.4 k5.4 k5 k9.3 k20 k12.7 k


1.7 b1.7 b

Current Assets

3.4 k5.9 k2.2 k2.6 k17.4 k10.5 k10.2 k38.1 k35.3 k41.4 k
USDFY, 2013FY, 2014

Net Income

626.5 m933.1 m

Depreciation and Amortization

516 m566.6 m


(160 m)(150 m)

Accounts Payable

137.2 m(300 k)
USDY, 2016

Financial Leverage

484.1 x
Show all financial metrics
Report incorrect company information